Transdermal Granisetron: A Guide to Its Use in Preventing Nausea and Vomiting Induced by Chemotherapy

被引：13

作者：

Keating, Gillian M. ^{[1
]}

Duggan, Sean T. ^{[1
]}

Curran, Monique P. ^{[1
]}

机构：

[1] Adis, Auckland 0754, New Zealand

来源：

CNS DRUGS | 2012年 / 26卷 / 09期

关键词：

THERAPEUTIC USE;

D O I：

10.2165/11209440-000000000-00000

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Transdermal granisetron (Sancuso (R)) is effective in the prevention of nausea and vomiting in patients with cancer who are receiving moderately or highly emetogenic chemotherapy for 3-5 days. Transdermal granisetron is noninferior to oral granisetron in this indication, and is generally well tolerated in this indication. Thus, transdermal granisetron provides a convenient option for the prevention of chemotherapy-induced nausea and vomiting, with the potential to improve patient compliance.

引用

页码：787 / 790

页数：4

共 50 条

[31] Granisetron and ondansetron for chemotherapy-related nausea and vomiting
Zeidman, A
Ben Dayan, D
Ben Zion, T
Kaufman, O
Cohen, AM
Mittelman, M
[J]. HAEMATOLOGIA, 1998, 29 (01) : 25 - 31
[32] Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
Hsu, Yu-Chen
Chen, Ching-Yao
Tam, Ka-Wai
Hsu, Chin-Yu
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (11) : 1597 - 1609
[33] Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis
Yu-Chen Hsu
Ching-Yao Chen
Ka-Wai Tam
Chin-Yu Hsu
[J]. European Journal of Clinical Pharmacology, 2021, 77 : 1597 - 1609
[34] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - REPLY
GEBBIA, V
CANNATA, G
GEBBIA, N
[J]. CANCER, 1995, 76 (03) : 536 - 536
[35] EFFICACY OF A TRANSDERMAL GRANISETRON PATCH IN CONTROLLING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN HEAD AND NECK CANCER PATIENTS.
Wong, Doris
Shelton, Gary
Braccia, Deborah
[J]. ONCOLOGY NURSING FORUM, 2015, 42 (02) : E222 - E222
[36] Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron
Coluzzi, Flaminia
Mattia, Consalvo
[J]. FUTURE ONCOLOGY, 2016, 12 (16) : 1865 - 1876
[37] Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting
Emma D. Deeks
[J]. Drugs, 2016, 76 : 1779 - 1786
[38] Granisetron Extended-Release Injection: A Review in Chemotherapy-Induced Nausea and Vomiting
Deeks, Emma D.
[J]. DRUGS, 2016, 76 (18) : 1779 - 1786
[39] OVERVIEW - ORAL GRANISETRON (KYTRIL TABLETS) PROPHYLAXIS FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
PEREZ, EA
[J]. SEMINARS IN ONCOLOGY, 1995, 22 (04) : 1 - 2
[40] TropisetronAn Update of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting
Kerryn Simpson
Caroline M. Spencer
Karen J. McClellan
[J]. Drugs, 2000, 59 : 1297 - 1315

← 1 2 3 4 5 →